ALPA LABORATORIES LIMITED

Business Segments Alpa Laboratories Limited

Stocks

ALPA

INE385I01010

Pharmaceuticals

Delayed NSE India S.E. 01:47:31 2026-09-09 EDT			5-day change	1st Jan Change
63.80 ^INR	+1.00%		+1.06%	-17.88%

08-13	Alpa Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2026	CI
07-22	Alpa Laboratories Ltd. Announces Cessation of Ms. Jyoti Jain as an Independent Director, Effective July 21, 2026	CI

Sales 2025 by Business Segment

© MarketScreener.com See more

Sales 2025 by Geography

© MarketScreener.com See more

Historical Breakdown of Revenue by Business Segments

Net Income: Breakdown by Business Segment

Geographical Revenue Distribution History

Breakdown by Business Segment (INR)

Fiscal Period: March	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Pharmaceutical Products
Drugs and Chemicals						976M	1.23B	930M	1.09B	1.12B
Total Assets						1.4B	1.55B	1.67B	1.82B	2.23B
Interest Expense						-261K	-1.07M	-825K	-3.23M	-2.32M
Income Tax Expense						35.39M	54.7M	33.08M	39.06M	61.64M
CAPEX						-32.17M	-21.9M	-11.26M	-63.85M	-114M
EBT						108M	196M	159M	207M	257M
D&A						12.29M	16.6M	13.29M	19.55M	22.02M
Net Income						72.47M	141M	126M	168M	195M

Geographical breakdown of sales (INR)

Fiscal Period: March	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Outside India						-	-	-	-	-
India						-	-	-	-	-

Rankings

Rankings

Currency / Forex

Commodities

Cryptocurrencies

Interest Rates

40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!

SEIZE THE OFFER!

×